Outcome of invasive mechanical ventilation after pediatric allogeneic hematopoietic SCT: Results from a prospective, multicenter registry

Bone Marrow Transplantation

Volumn 49, Issue 10, 2014, Pages 1287-1292

  Van Gestel, J P J ^a   Bierings, M B ^a   Dauger, S ^b   Dalle, J H ^b   Pavlicek P ^c   Sedlacek P ^c   Monteiro, L M ^d   Lankester, A ^d   Bollen, C W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; CZECH REPUBLIC; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRANCE; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INVASIVE MECHANICAL VENTILATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NETHERLANDS; NONINVASIVE VENTILATION; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RISK FACTOR; TREATMENT DURATION; ALLOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84926406605     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.147     Document Type: Article

References (37)

1. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 25: 2091-2101.
2. Oshima K, Hanada R, Kobayashi R, Kato K, Nagatoshi Y, Tabuchi K et al. Hematopoietic stem cell transplantation in patients with severe congenital neutropenia: an analysis of 18 Japanese cases. Pediatr Transplant 2010; 14: 657-663.
3. Bhatia M, Walters MC. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant 2008; 41: 109-117.
4. Boelens JJ. Trends in haematopoietic cell transplantation for inborn errors of metabolism. J Inherit Metab Dis 2006; 29: 413-420.
5. van Gestel JP, Bollen CW, van der Tweel I, Boelens JJ, van Vught AJ. Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression analysis. Crit Care Med 2008; 36: 2898-2904.
6. Duncan CN, Lehmann LE, Cheifetz IM, Greathouse K, Haight AE, Hall MW et al. Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant. Pediatr Crit Care Med 2013; 14: 261-267.
7. Nichols DG, Walker LK, Wingard JR, Bender KS, Bezman M, Zahurak ML et al. Predictors of acute respiratory failure after bone marrow transplantation in children. Crit Care Med 1994; 22: 1485-1491.
8. van Gestel JP, Bollen CW, Bierings MB, Boelens JJ, Wulffraat NM, van Vught AJ. Survival in a recent cohort of mechanically ventilated pediatric allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2008; 14: 1385-1393.
9. Tamburro RF, Barfield RC, Shaffer ML, Rajasekaran S, Woodard P, Morrison RR et al. Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation. Pediatr Crit Care Med 2008; 9: 270-277.
10. Cole TS, Johnstone IC, Pearce MS, Fulton B, Cant AJ, Gennery AR et al. Outcome of children requiring intensive care following haematopoietic SCT for primary immunode ficiency and other non-malignant disorders. Bone Marrow Transplant 2012; 47: 40-45.
11. Aspesberro F, Guthrie KA, Woolfrey AE, Brogan TV, Roberts JS. Outcome of pediatric hematopoietic stem cell transplant recipients requiring mechanical ventilation. J Intens Care Med 2014; 29: 31-37.
12. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
13. Wilkinson JD, Pollack MM, Glass NL, Kanter RK, Katz RW, Steinhart CM. Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 1987; 111: 324-328.
14. Keenan HT, Bratton SL, Martin LD, Crawford SW, Weiss NS. Outcome of children who require mechanical ventilatory support after bone marrow transplantation. Crit Care Med 2000; 28: 830-835.
15. Slater A, Shann F, Pearson G. PIM2: a revised version of the paediatric index of mortality. Intens Care Med 2003; 29: 278-285.
16. Jacobe SJ, Hassan A, Veys P, Mok Q. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation. Crit Care Med 2003; 31: 1299-1305.
17. Demaret P, Pettersen G, Hubert P, Teira P, Emeriaud G. The critically-ill pediatric hemato-oncology patient: epidemiology, management, and strategy of transfer to the pediatric intensive care unit. Ann Intens Care 2012; 2: 14.
18. Tomaske M, Bosk A, Eyrich M, Bader P, Niethammer D. Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation. Br J Haematol 2003; 121: 886-891.
19. Kache S, Weiss IK, Moore TB. Changing outcomes for children requiring intensive care following hematopoietic stem cell transplantation. Pediatr Transplant 2006; 10: 299-303.
20. Flores FX, Brophy PD, Symons JM, Fortenberry JD, Chua AN, Alexander SR et al. Continous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol 2008; 23: 625-630.
21. Modem V, Thompson M, Gollhofer D, Dhar AV, Quigley R. Timing of continuous renal replacement therapy and mortality in critically ill children. Crit Care Med 2014; 42: 943-953.
22. Broers AE, van der Holt R, van Esser JW, Gratama JW, Henzen-Logmans S, Kuenen-Boumeester V et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 2000; 95: 2240-2245.
23. Schmidt-Hieber M, Labopin M, Beelen D, Volin L, Ehninger G, Finke J et al. CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT. Blood 2013; 122: 3359-3364.
24. Matthes-Martin S, Potschger U, Bergmann K, Frommlet F, Brannath W, Bauer P et al. Risk-adjusted outcome measurement in pediatric allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 335-343.
25. McArthur J, Pettersen G, Jouvet P, Christensen M, Tamburro R. The care of critically ill children after hematopoietic SCT: a North American survey. Bone Marrow Transplant 2011; 46: 227-231.
26. Thiery G, Azoulay E, Darmon M, Ciroldi M, De MS, Levy V et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406-4413.
27. Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808-814.
28. Azoulay E, Mokart D, Pene F, Lambert J, Kouatchet A, Mayaux J et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium - a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 2013; 31: 2810-2818.
29. Straney L, Clements A, Parslow RC, Pearson G, Shann F, Alexander J et al. Paediatric index of mortality 3: an updated model for predicting mortality in pediatric intensive care∗. Pediatr Crit Care Med 2013; 14: 673-681.
30. Cheuk DK, Ha SY, Lee SL, Chan GC, Tsoi NS, Lau YL. Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant. Hematol Oncol 2004; 22: 1-9.
31. Gonzalez-Vicent M, Marin C, Madero L, Sevilla J, Diaz MA. Risk score for pediatric intensive care unit admission in children undergoing hematopoietic stem cell transplantation and analysis of predictive factors for survival. J Pediatr Hematol Oncol 2005; 27: 526-531.
32. Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29: 519-525.
33. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481-487.
34. Molina R, Bernal T, Borges M, Borges M, Zaragoz R, Bonastre J et al. Ventilatory support in critically ill hematology patients with respiratory failure. Crit Care 2012; 16: R133.
35. Adda M, Coquet I, Darmon M, Thiery G, Schlemmer B, Azoulay E. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 2008; 36: 2766-2772.
36. Schnell D, Lemiale V, Azoulay E. Non-invasive mechanical ventilation in hematology patients: let's agree on several things first. Crit Care 2012; 16: 175.
37. Azoulay E, Lemiale V. Non-invasive mechanical ventilation in hematology patients with hypoxemic acute respiratory failure: a false belief? Bone Marrow Transplant 2012; 47: 469-472.